Announcement
12 Jul 2021
In July 2021, Bpifrance provided Inotrem SA with public financing for developing a treatment of severe forms of COVID-19.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
1 in force
Implementation date
12 Jul 2021
Revocation date:
No revocation date
On 12 July 2021, Bpifrance announced the provision of EUR 45 million (approx. USD 53.4 million) financing to Inotrem SA for the clinical development of a treatment of patients with severe symptoms of ...
See all
This state act is not part of any Thread yet.